# Enbridge Inc: financial statements, quarterly

ENB · NYSE · CIK 895728 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/enb.md) · [Financials](/companies/enb/financials.md) · [Filings](/companies/enb/filings.md) · [Insiders](/companies/enb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/enb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.2](/filings/0000895728-24-000028.md) | [11.3](/filings/0000895728-25-000006.md) | [6.8](/filings/0000895728-25-000012.md) | [5.9](/filings/0000950170-25-101102.md) | [5.7](/filings/0001193125-25-270991.md) | [16.2](/filings/0001193125-26-049810.md) | [8.8](/filings/0001193125-26-213266.md) | [6.5](/filings/0001193125-26-326752.md) | [6.1](/filings/0001193125-25-270991.md) | [17.2](/filings/0001193125-26-049810.md) | [9.0](/filings/0001193125-26-213266.md) | [6.6](/filings/0001193125-26-326752.md) |
| Cost of revenue | $bn | [4.8](/filings/0000895728-24-000028.md) | [5.4 d](/filings/0000895728-24-000007.md) | [5.0](/filings/0000895728-24-000013.md) | [5.5](/filings/0000895728-24-000020.md) | [9.1](/filings/0000895728-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [1.8](/filings/0000895728-25-000006.md) | [1.8](/filings/0000895728-25-000006.md) | [2.7](/filings/0001193125-26-049810.md) | [2.3](/filings/0001193125-26-049810.md) | [2.2](/filings/0001193125-26-049810.md) | [2.4](/filings/0001193125-26-049810.md) | [3.7](/filings/0001193125-26-213266.md) | [2.3](/filings/0001193125-26-326752.md) | [2.3](/filings/0001193125-26-049810.md) | [2.7](/filings/0001193125-26-049810.md) | [3.2](/filings/0001193125-26-213266.md) | [2.9](/filings/0001193125-26-326752.md) |
| Interest expense | $bn | [0.9](/filings/0000895728-23-000033.md) | [1.1 d](/filings/0001193125-26-049810.md) | [0.9](/filings/0000895728-24-000013.md) | [1.1](/filings/0000950170-25-101102.md) | [1.3](/filings/0001193125-25-270991.md) | [1.1 d](/filings/0001193125-26-049810.md) | [1.3](/filings/0001193125-26-213266.md) | [1.2](/filings/0001193125-26-326752.md) | [1.3](/filings/0001193125-25-270991.md) | [1.2 d](/filings/0001193125-26-049810.md) | [1.2](/filings/0001193125-26-213266.md) | [1.4](/filings/0001193125-26-326752.md) |
| Income tax | $bn | [0.1](/filings/0000895728-24-000028.md) | [0.7 d](/filings/0001193125-26-049810.md) | [0.4](/filings/0000895728-25-000012.md) | [0.7](/filings/0000950170-25-101102.md) | [0.3](/filings/0001193125-25-270991.md) | [0.2 d](/filings/0001193125-26-049810.md) | [0.7](/filings/0001193125-26-213266.md) | [0.7](/filings/0001193125-26-326752.md) | [0.3](/filings/0001193125-25-270991.md) | [0.3 d](/filings/0001193125-26-049810.md) | [0.6](/filings/0001193125-26-213266.md) | [0.4](/filings/0001193125-26-326752.md) |
| Net income | $bn | [0.6](/filings/0000895728-25-000006.md) | [1.8](/filings/0000895728-25-000006.md) | [1.5](/filings/0001193125-26-049810.md) | [1.9](/filings/0001193125-26-049810.md) | [1.4](/filings/0001193125-26-049810.md) | [0.6](/filings/0001193125-26-049810.md) | [2.4](/filings/0001193125-26-213266.md) | [2.3](/filings/0001193125-26-326752.md) | [0.8](/filings/0001193125-26-049810.md) | [2.1](/filings/0001193125-26-049810.md) | [1.8](/filings/0001193125-26-213266.md) | [1.5](/filings/0001193125-26-326752.md) |
| Diluted EPS | $ per share | [0.26](/filings/0000895728-25-000006.md) | [0.81](/filings/0000895728-25-000006.md) | [0.67](/filings/0001193125-26-049810.md) | [0.86](/filings/0001193125-26-049810.md) | [0.59](/filings/0001193125-26-049810.md) | [0.23](/filings/0001193125-26-049810.md) | [1.03](/filings/0001193125-26-213266.md) | [1.00](/filings/0001193125-26-326752.md) | [0.30](/filings/0001193125-26-049810.md) | [0.89](/filings/0001193125-26-049810.md) | [0.76](/filings/0001193125-26-213266.md) | [0.64](/filings/0001193125-26-326752.md) |
| Basic EPS | $ per share | [0.26](/filings/0000895728-25-000006.md) | [0.81](/filings/0000895728-25-000006.md) | [0.67](/filings/0001193125-26-049810.md) | [0.86](/filings/0001193125-26-049810.md) | [0.59](/filings/0001193125-26-049810.md) | [0.23](/filings/0001193125-26-049810.md) | [1.04](/filings/0001193125-26-213266.md) | [1.00](/filings/0001193125-26-326752.md) | [0.30](/filings/0001193125-26-049810.md) | [0.89](/filings/0001193125-26-049810.md) | [0.77](/filings/0001193125-26-213266.md) | [0.64](/filings/0001193125-26-326752.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.6](/filings/0000895728-23-000033.md) | [5.9](/filings/0000895728-25-000006.md) | [1.2](/filings/0000895728-24-000013.md) | [3.6](/filings/0000895728-24-000020.md) | [1.9](/filings/0000895728-24-000028.md) | [1.8](/filings/0001193125-26-049810.md) | [2.1](/filings/0000895728-25-000012.md) | [1.2](/filings/0000950170-25-101102.md) | [1.4](/filings/0001193125-25-270991.md) | [1.1](/filings/0001193125-26-326752.md) | [1.6](/filings/0001193125-26-213266.md) | [2.0](/filings/0001193125-26-326752.md) |
| Current assets | $bn | [11.1](/filings/0000895728-23-000033.md) | [14.4](/filings/0000895728-25-000006.md) | [10.0](/filings/0000895728-24-000013.md) | [12.5](/filings/0000895728-24-000020.md) | [11.9](/filings/0000895728-24-000028.md) | [13.2](/filings/0001193125-26-049810.md) | [13.6](/filings/0000895728-25-000012.md) | [11.1](/filings/0000950170-25-101102.md) | [12.1](/filings/0001193125-25-270991.md) | [13.2](/filings/0001193125-26-326752.md) | [18.9](/filings/0001193125-26-213266.md) | [17.7](/filings/0001193125-26-326752.md) |
| Total assets | $bn | [178](/filings/0000895728-23-000033.md) | [180](/filings/0000895728-25-000006.md) | [191](/filings/0000895728-24-000013.md) | [201](/filings/0000895728-24-000020.md) | [206](/filings/0000895728-24-000028.md) | [219](/filings/0001193125-26-049810.md) | [220](/filings/0000895728-25-000012.md) | [212](/filings/0000950170-25-101102.md) | [217](/filings/0001193125-25-270991.md) | [218](/filings/0001193125-26-326752.md) | [228](/filings/0001193125-26-213266.md) | [232](/filings/0001193125-26-326752.md) |
| Current liabilities | $bn | [16.7](/filings/0000895728-23-000033.md) | [17.4](/filings/0000895728-25-000006.md) | [14.7](/filings/0000895728-24-000013.md) | [16.3](/filings/0000895728-24-000020.md) | [19.1](/filings/0000895728-24-000028.md) | [23.8](/filings/0001193125-26-049810.md) | [18.6](/filings/0000895728-25-000012.md) | [14.8](/filings/0000950170-25-101102.md) | [15.0](/filings/0001193125-25-270991.md) | [21.0](/filings/0001193125-26-326752.md) | [23.3](/filings/0001193125-26-213266.md) | [24.6](/filings/0001193125-26-326752.md) |
| Total liabilities | $bn | [110](/filings/0000895728-23-000033.md) | [116](/filings/0000895728-25-000006.md) | [123](/filings/0000895728-24-000013.md) | [131](/filings/0000895728-24-000020.md) | [137](/filings/0000895728-24-000028.md) | [150](/filings/0001193125-26-049810.md) | [149](/filings/0000895728-25-000012.md) | [143](/filings/0000950170-25-101102.md) | [148](/filings/0001193125-25-270991.md) | [153](/filings/0001193125-26-326752.md) | [160](/filings/0001193125-26-213266.md) | [163](/filings/0001193125-26-326752.md) |
| Long-term debt | $bn | not reported | [0.5](/filings/0000895728-24-000007.md) | not reported | not reported | not reported | [102](/filings/0000895728-25-000006.md) | not reported | not reported | not reported | [104](/filings/0001193125-26-049810.md) | not reported | not reported |
| Current portion of debt | $bn | not reported | [0.1](/filings/0000895728-24-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [1.6](/filings/0000895728-23-000033.md) | [0.4](/filings/0000895728-25-000006.md) | [0.3](/filings/0000895728-24-000013.md) | [0.2](/filings/0000895728-24-000020.md) | [0.9](/filings/0000895728-24-000028.md) | [0.5](/filings/0001193125-26-049810.md) | [0.9](/filings/0000895728-25-000012.md) | [0.9](/filings/0000950170-25-101102.md) | [1.3](/filings/0001193125-25-270991.md) | [1.0](/filings/0001193125-26-326752.md) | [1.5](/filings/0001193125-26-213266.md) | [1.6](/filings/0001193125-26-326752.md) |
| Shareholders' equity | $bn | [65.1](/filings/0000895728-23-000033.md) | [61.5](/filings/0000895728-25-000006.md) | [64.3](/filings/0000895728-24-000013.md) | [67.2](/filings/0000895728-24-000020.md) | [65.8](/filings/0000895728-24-000028.md) | [65.9](/filings/0001193125-26-049810.md) | [68.3](/filings/0000895728-25-000012.md) | [65.4](/filings/0000950170-25-101102.md) | [65.2](/filings/0001193125-25-270991.md) | [62.3](/filings/0001193125-26-326752.md) | [65.0](/filings/0001193125-26-213266.md) | [65.3](/filings/0001193125-26-326752.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,084 d](/filings/0000895728-24-000028.md) | [3,812 d](/filings/0001193125-26-049810.md) | [3,151](/filings/0000895728-25-000012.md) | [2,814 d](/filings/0000950170-25-101102.md) | [2,973 d](/filings/0001193125-25-270991.md) | [3,662 d](/filings/0001193125-26-049810.md) | [3,053](/filings/0001193125-26-213266.md) | [3,238 d](/filings/0001193125-26-326752.md) | [2,868 d](/filings/0001193125-25-270991.md) | [3,111 d](/filings/0001193125-26-049810.md) | [2,342](/filings/0001193125-26-213266.md) | [4,111 d](/filings/0001193125-26-326752.md) |
| Capital expenditure | $m | [1,191 d](/filings/0000895728-24-000028.md) | [1,370 d](/filings/0001193125-26-049810.md) | [1,185](/filings/0000895728-25-000012.md) | [1,348 d](/filings/0000950170-25-101102.md) | [1,632 d](/filings/0001193125-25-270991.md) | [2,546 d](/filings/0001193125-26-049810.md) | [1,723](/filings/0001193125-26-213266.md) | [1,900 d](/filings/0001193125-26-326752.md) | [2,321 d](/filings/0001193125-25-270991.md) | [3,029 d](/filings/0001193125-26-049810.md) | [2,439](/filings/0001193125-26-213266.md) | [2,975 d](/filings/0001193125-26-326752.md) |
| Dividends paid | $m | [1,795 d](/filings/0000895728-24-000028.md) | [1,886 d](/filings/0001193125-26-049810.md) | [1,945](/filings/0000895728-25-000012.md) | [1,945 d](/filings/0000950170-25-101102.md) | [1,995 d](/filings/0001193125-25-270991.md) | [1,990 d](/filings/0001193125-26-049810.md) | [2,054](/filings/0001193125-26-213266.md) | [2,055 d](/filings/0001193125-26-326752.md) | [2,055 d](/filings/0001193125-25-270991.md) | [2,056 d](/filings/0001193125-26-049810.md) | [2,116](/filings/0001193125-26-213266.md) | [2,120 d](/filings/0001193125-26-326752.md) |
| Share repurchases | $m | [0.0 d](/filings/0000895728-24-000028.md) | [0.0 d](/filings/0001193125-26-049810.md) | not reported | not reported | [0.0 d](/filings/0000895728-24-000028.md) | [0.0 d](/filings/0001193125-26-049810.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,028](/filings/0000895728-23-000033.md) | [2,028](/filings/0000895728-24-000013.md) | [2,027](/filings/0000895728-24-000020.md) | [2,049](/filings/0000895728-24-000028.md) | [2,128](/filings/0000895728-25-000012.md) | [2,139](/filings/0000950170-25-101102.md) | [2,180](/filings/0001193125-25-270991.md) | [2,185](/filings/0001193125-26-213266.md) | [2,186](/filings/0001193125-26-326752.md) | [2,187](/filings/0001193125-25-270991.md) | [2,188](/filings/0001193125-26-213266.md) | [2,190](/filings/0001193125-26-326752.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,184,085,509 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-326752.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.